Vaspin Levels Compared With Serum Insulin and Blood Glucose Levels in Neonates
- Conditions
- Insulin Sensitivity
- Registration Number
- NCT01363622
- Lead Sponsor
- Zekai Tahir Burak Women's Health Research and Education Hospital
- Brief Summary
The aim of this study was to investigate circulating concentrations of vaspin in fetal and neonatal samples from SGA, AGA and LGA with the respective insulin concentrations. Serum vaspin concentrations were determined by enzyme immunoassay in 22 SGA and 30 LGA and 30 AGA singleton full-term fetuses and neonates on cord blood and postnatal day 5.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 82
Inclusion Criteria
- Full term healthy infant
Exclusion Criteria
- sepsis
- congenital anomaly
- sick infant
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms link vaspin to insulin sensitivity in neonatal metabolic disorders?
How do vaspin levels in SGA neonates compare with standard biomarkers for metabolic syndrome risk?
Are vaspin concentrations in cord blood predictive of long-term glucose metabolism outcomes in LGA infants?
What adverse metabolic events are associated with elevated vaspin in full-term neonates and how are they managed?
How does vaspin expression in fetal tissues relate to other adipokines like adiponectin in AGA and SGA neonates?
Trial Locations
- Locations (1)
Zekai Tahir Burak Maternity Teaching Hospital
🇹🇷Ankara, Turkey
Zekai Tahir Burak Maternity Teaching Hospital🇹🇷Ankara, TurkeyAhmet Akcay, MDContactahmet1906ak@windowslive.com